Fact Sheet – LIS Formulary Drug Coverage
Guidance for comparison of LIS and non-LIS formularies from CY 2013 through CY 2016 to identify whether access issues exist on LIS plan formularies, as measured by drug coverage, brand drug coverage and use of utilization management edits.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 01, 2020
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.